Cell therapy Archives

In Depth 9 Dec 2024

CAR-T cell therapy for lupus: An emerging field with great potential

Discover how the emerging field of using CAR-T cell therapy to treat lupus could offer a potential cure for the autoimmune disorder.

December 9, 2024 - 10 minutesmins - By Willow Shah-Neville

Unlocking consistency in ATMP development: How cryopreservation strengthens Europe’s cell therapy supply chain

Discover how innovative cell therapy cryopreservation solutions are strengthening Europe’s ATMP supply chain.

November 12, 2024 - 5 minutesmins - By External Contributor

In Depth 30 Oct 2024

Could next-generation “switchable” CAR-T cells help improve the safety and efficacy of CAR-T therapies?

Discover how next-generation “switchable” CAR-T cells could improve both the safety and efficacy of CAR-T therapies.

October 30, 2024 - 8 minutesmins - By Willow Shah-Neville

cellular reprogramming with Shift Bioscience

News and Trends 21 Oct 2024

Turning back time with cellular reprogramming: Shift raises $16 million in seed funding

As Shift Bioscience raises $16 million in seed funding, delve into the field of cellular reprogramming to tackle age-related diseases.

October 21, 2024 - 9 minutesmins - By Jules Adam

In Depth 7 Oct 2024

Spinal cord injury: Are we getting closer to a treatment?

Delve into the spinal cord injury treatment landscape with a few pharmaceutical approaches that could tackle this complex condition.

October 7, 2024 - 8 minutesmins - By Jules Adam

News and Trends 3 Oct 2024

Resolution Therapeutics raises $85 million to advance its macrophage therapy

Find out about Resolution Therapeutics’ macrophage therapy, as it just raised $85 million in a series B round.

October 3, 2024 - 7 minutesmins - By Jules Adam

Mastering regulations and supply chain for advanced therapies

Navigating your path to globalization: Untangling the regulatory maze of the Advanced Therapies supply chain

Discover how Cryoport Systems can help you navigate EMEA regulations and manage the supply chain complexities for advanced therapies.

August 27, 2024 - 6 minutesmins - By External Contributor

Podcast 26 Jul 2024

The first mass-market cell therapy?

Listen to our conversation with CEO Greg Kunst about how Aurion’s treatment could be the first mass-market cell therapy available

July 26, 2024

Cryoport: overcoming obstacles in advanced therapies development in Europe

Overcoming obstacles as advanced therapies continue to evolve in Europe

Discover strategies to overcome the challenges in advanced therapy development in Europe’s evolving biopharmaceutical landscape.

June 18, 2024 - 6 minutesmins - By External Contributor

Best in Biotech 13 Jun 2024

Eight companies tackling cancer with allogeneic cell therapy in 2024

Unlike autologous cell therapy, where the patient’s own cells are used, allogeneic cell therapy companies leverage donor cells, which can come from various sources such as bone marrow or umbilical cord blood. In allogeneic cell therapy, healthy donor cells are harvested, processed, and then infused into the patient. These donor cells can differentiate into various […]

June 13, 2024 - 9 minutesmins - By Jules Adam

Podcast 31 May 2024

Can cell therapy tackle hearing loss

Hearing loss is a growing global challenge. UK-based Rinri Therapeutics is developing a portfolio of off-the-shelf regenerative cell therapy products to address sensorineural hearing loss.

May 31, 2024

Best in Biotech 30 May 2024

Stem cell therapy’s avant-garde: Eight companies leading the way

Stem cell therapy has gained traction over the recent years and the market is growing, discover eight companies advancing the field.

May 30, 2024 - 11 minutesmins - By Jules Adam

Resources

Categories

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Cell therapy

CAR-T cell therapy for lupus: An emerging field with great potential

Unlocking consistency in ATMP development: How cryopreservation strengthens Europe’s cell therapy supply chain

Could next-generation “switchable” CAR-T cells help improve the safety and efficacy of CAR-T therapies?

Turning back time with cellular reprogramming: Shift raises $16 million in seed funding

Spinal cord injury: Are we getting closer to a treatment?

Resolution Therapeutics raises $85 million to advance its macrophage therapy

Navigating your path to globalization: Untangling the regulatory maze of the Advanced Therapies supply chain

The first mass-market cell therapy?

Overcoming obstacles as advanced therapies continue to evolve in Europe

Eight companies tackling cancer with allogeneic cell therapy in 2024

Can cell therapy tackle hearing loss

Stem cell therapy’s avant-garde: Eight companies leading the way

Subscribe to our newsletter to get the latest biotech news!

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!